Therapixel

Therapixel is a software company specialized in artificial intelligence for medical imaging analysis

Last Funding Type: Series B
Last Funding Money Raised: €15M
Industries: Artificial Intelligence,Health Diagnostics,Machine Learning,Medical Device,Software
Founded date: Jan 1, 2013
Number Of Employee: 11 - 50
Operating Status: Active

Therapixel develops and commercializes AI-based software for breast cancer detection and characterization

Number of Funding Rounds

Total Funding Amount

2

€15.60M

Therapixel has raised a total of €15.60M in funding over 2 rounds. Their latest funding was raised on May 12, 2022 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
May 12, 2022	Series B	€15M	1	—	—	Detail
Nov 24, 2015	Seed	€600K	1	—	—	Detail

Number of Lead Investors

Number of Investors

—

2

Therapixel is funded by 2 investors. Verve Ventures and Conseil Plus Gestion are the most recent investors.

Investor Name	Lead Investor	Funding Round
Verve Ventures	—	Series B
Conseil Plus Gestion	—	Seed